Background: A challenge for R2 and R2* methods in measuring liver iron concentration (LIC) is that fibrosis, fat, and other hepatic cellular pathology contribute to R2 and R2* and interfere with LIC estimation. Purpose: To examine the interfering effects of fibrosis, fat, and other lesions on R2* LIC estimation and to use quantitative susceptibility mapping (QSM) to reduce these distortions. Study Type: Prospective. Phantoms, Subjects: Water phantoms with various concentrations of gadolinium (Gd), collagen (Cl, modeling fibrosis), and fat; nine healthy controls with no known hepatic disease, nine patients with known or suspected hepatic iron overload, and nine patients with focal liver lesions. Field Strength/Sequence: The phantoms and human subjects were imaged using a 3D multiecho gradient-echo on clinical 1.5T and 3T MRI systems. Assessment: QSM and R2* images were postprocessed from the same gradient-echo data. Fat contributions to susceptibility and R2* were corrected in signal models for LIC estimation. Statistical Tests: Polynomial regression analyses were performed to examine relations among susceptibility, R2* and true [Gd] and [Cl] in phantoms, and among susceptibility and R2* in patient livers. Results: In phantoms, R2* had a strong nonlinear dependency on [Cl], [fat], and [Gd], while susceptibility was linearly dependent (R 2 > 0.98). In patients, R2* was highly sensitive to liver pathological changes, including fat, fibrosis, and tumors, while QSM was relatively insensitive to these abnormalities (P 5 0.015). With moderate iron overload, liver susceptibility and R2* were not linearly correlated over a common R2* range [0, 100] sec 21 (P 5 0.35). Data Conclusion: R2* estimation of LIC is prone to substantial nonlinear interference from fat, fibrosis, and other lesions. QSM processing of the same gradient echo MRI data can effectively minimize the effects of cellular pathology. Level of Evidence: 1 Technical Efficacy: Stage 1
M easurement of liver iron concentration (LIC) is critical for assessing the magnitude of the body iron burden in the diagnosis and management of both hereditary and acquired forms of iron overload. 1 During iron overload, the amount of iron in the functional and transport pools changes only slightly, with almost all the excess iron sequestered in the paramagnetic state. Specifically, the excess iron is stored as ferric iron in ferritin and hemosiderin, and is deposited in the liver in hepatocytes and macrophages. 2 Magnetic resonance imaging (MRI) is highly sensitive to paramagnetic iron and has emerged as the primary noninvasive modality for tissue iron quantification needed in evaluating iron overload and monitoring iron chelating therapy. 3 The transverse relaxation rate R2 (51/T 2 ), and the faster and more sensitive R2* (51/T 2 *), have been measured by commercially available MRI pulse sequences to quantify LIC. 4, 5 A major challenge for the R2 and R2* methods in measuring LIC is that fibrosis, fat, and other histologic changes in hepatic cellularity contribute to R2 and R2* and interfere with LIC estimation. 6 Given that an eventual consequence of liver iron overload is the induction of fibrosis, hepatic fibrosis is reported in 50-94% of patients with transfusional iron overload. 4, 7, 8 Fibrosis effects may contribute to the large error range [-71%, 74%] in the current US Food and Drug Administration (FDA)-approved R2-based LIC measurement. 5, 8 These errors in liver iron estimation can thus be problematic in clinical practice. For example, a patient with an R2 LIC of 5.0 mg Fe/g liver dry weight (dw), which is within the optimal range of iron-chelating therapy for thalassemia major patients, 9 may have a biopsy LIC ranging from 1.5 mg Fe/g dw, indicating that chelator administration should be stopped to avoid chelator toxicity, 9 to 8.7 mg Fe/g dw, indicating that the chelator dose should be increased to avoid iron toxicity. 9 Using data from livers with cirrhosis and other lesions, some authors suggest that the large error range is the consequence of variability in biopsy samples. 5 Several studies, including a recent prospective study in patients with transfusional liver iron overload, 10 have consistently demonstrated that the biopsy sampling error is about 7% with adequate biopsy samples (!1 mg dw) in the absence of cirrhosis. 10, 11 A correction for fat chemical shift as a confounding contribution to R2* estimation from the MRI signal has recently been established 12 and constitutes an important advance in fatty liver LIC estimation. 3 However, the biophysical connection between LIC and R2* remains unexamined and needs consideration. The biophysical connection between iron and R2* has been investigated in the context of quantifying oxygen consumption or paramagnetic iron in deoxyheme in brain functional (f )MRI or calibrated fMRI, 13 and demonstrates that the relationship between R2* and iron concentration is complex and nonlinear. In general, R2 and R2* are sensitive to, and depend on, the microenvironment of water interactions, the spatial distribution of iron within a voxel, and sources of interference such as fat and fibrosis. These interfering effects are difficult to model quantitatively and to compensate for in iron quantification. 13 While the magnitude data of the multiecho gradientecho (GRE) MRI are used to generate R2*, the phase data can be used to generate quantitative susceptibility maps (QSM) to directly measure magnetic susceptibility 14, 15 without blooming artifacts found in R2*. 16 
Materials and Methods

Phantom
Collagen is a major component of liver fibrosis 27 and was used to model fibrosis in vitro. A paramagnetic gadolinium (Gd) contrast agent, instead of iron oxide nanoparticle agent, 28 
Human Subjects
Nine healthy controls with no known hepatic disease, nine patients with known or suspected hepatic iron overload, and nine patients with focal liver lesions participated in this Institutional Review Board (IRB)-approved Health Insurance Portability and Accountability Act (HIPAA)-compliant study. All participants provided written informed consent. Subjects with iron overload had either thalassemia (n 5 2), myelodysplastic syndrome (n 5 5), or cirrhosis (n 5 2).
MRI
The collagen-water-Gd and fat-water-Gd phantoms were studied using a clinical 3.0T MRI system (Magnetom Trio Tim; Siemens Healthcare, Erlangen, Germany). QSM and R2* maps of the phantoms were obtained from the same 3D unipolar readout multiecho GRE sequence with the following parameters: repetition time (TR) 5 30 msec, echo time (TE 1 ) 5 1.24 msec, DTE 5 2.08 msec, number of echoes 5 8, flip angle (FA) 5 108, matrix size 5 256 3 232 3 48, spatial resolution 5 1.5 3 1.5 3 2.0 mm. To reduce the noise floor effect and accurately measure R2*, three more interleaved shots were acquired and a total of 32 echoes with echo space of 0.52 msec were used for magnitude fitting.
The subjects with no known hepatic disease, and those with known or suspected hepatic iron overload, were studied using a clinical 1.5T MRI system (Magnetom Aera; Siemens Healthcare) with a combination of spine and torso coils. Liver QSM and R2* maps were obtained from the same 3D bipolar readout multiecho GRE sequence with the following parameters: TR 5 10.0 msec, TE 1 5 1.44 msec, DTE 5 1.36 msec, number of echoes 5 6, FA 5 68, matrix size 5 224 3 168 3 44, spatial resolution 5 1.7 3 1.7 3 5.0 mm. Additionally, a generalized autocalibrating partially parallel acquisition with acceleration factor of 2 in the anterior-posterior direction and elliptical sampling were used to reduce acquisition time. 19 The scans lasted 14 seconds and were readily completed during a single breath-hold. The subjects with focal lesions were imaged using a clinical 3.0T MRI system (Magnetom Verio; Siemens Healthcare). QSM and R2* maps of the liver were obtained from the same 3D unipolar readout GRE sequence with the following parameters: TR 5 14.0 msec, TE 1 5 1.49 msec, DTE 5 2.06 msec, number of echoes 5 6, FA 5 108, matrix size 5 256 3 176 3 26, spatial resolution 5 1.5 3 1.5 3 5.0 mm. The scans lasted 20 seconds and were completed during a single breath-hold. Conventional MR images, including T 1 -weighted, T 2 -weighted, diffusion-weighted, and postcontrast T 1 -weighted images, were also acquired for complete lesion assessment.
QSM and R2* Reconstruction
Phase images were extracted from the complex MRI data. Phase discrepancies between odd and even echoes in the bipolar readout gradients caused by nonideal gradient behaviors were first measured, modeled as polynomials in space, and corrected in field mapping. Simultaneous Phase Unwrapping and Removal of chemical Shift (SPURS) 24 using graph cuts with conditional jump moves was then performed on the phase images, followed by field map fine-tuning with T 2 *-IDEAL with a single R2* model for combined water-fat. 12 The SPURS-T 2 *-IDEAL output was then processed with background field removal using the projectiononto-dipole-field method, and the remaining magnetic field was processed to generate a susceptibility map using the morphology enabled dipole inversion algorithm. 29 A schematic view of QSM reconstruction is shown in Fig. 1 . For R2* mapping of the fat-water-Gd phantoms and liver, Levenberg-Marquardt nonlinear fitting was used to fit the magnitude components of the multiecho data with the multipeak fat model after complex-based water-fat separation, 12 with dual-echo flexible-TE method for data from the 1.5T MRI system, and IDEAL method for data from the 3T MRI system. A single R2* model for combined water-fat was used for both the fat-water-Gd phantoms and liver.
Data Analysis
Liver magnetic susceptibility was measured on QSM using region of interest (ROI) analysis. The latissimus dorsi muscle, regarded as not being affected by transfusional iron overload, 30 was used as the zero reference for susceptibility. ROIs of $12 cm 2 were placed on the liver region away from major vessels. ROIs of $4 cm 2 were placed on the nearby latissimus dorsi muscle. ROIs for focal lesions were placed in the lesions, with an area corresponding to just below lesion size. Contrast-to-noise ratio (CNR) of lesion to neighboring normalappearing liver was measured in R2* and in susceptibility maps for each patient with focal liver lesions. Noise was defined as the standard deviation of signal intensity of neighboring normal appearing liver. The fat contribution to liver susceptibility was calculated according to an estimated relative fat density, and was removed from the measured liver susceptibility to generate fat-corrected QSM. Our implementation of relative fat density estimation included the following steps: intensity inhomogeneity due to receiver coils was first estimated using a level set method 31 and was then used to scale the fat image into a relative fat density estimate. The fat contribution to liver susceptibility v F was calculated using the following equation:
where q F is the signal intensity of liver in the fat image. Human adipose tissue is composed largely of oleic acid and pure oleic acid has a volume susceptibility X OA 5 0.75 ppm. 32 q OA is the mean signal intensity of regions with subcutaneous fat in the fat image. Equation 1 assumes that subcutaneous fat is pure oleic acid and overcomes the relative fat density division difficulties in poor signal regions. Statistical analyses were carried out using SPSS for Windows v. 17.0 (Chicago, IL). Linear regression analysis was performed to compare liver magnetic susceptibility with liver R2*. Correlation equations where R2* or susceptibility depends on the chemical composition were calculated using a nonlinear fitting procedure (cftool) in MatLab 2014b (MathWorks, Natick, MA). The fat contribution to the measured susceptibility was estimated using data without Gd and then corrected for all fat-water-Gd phantoms.
Results Figure 2 shows the measured R2* and susceptibility maps from collagen-water-Gd phantoms. At [Gd] 5 1.25 mmol/L, an FIGURE 1: Schematic view of the liver QSM process. First, SPURS initializes the inhomogeneity magnetic field (b) with R2* initialized with zero. Second, T 2 *-IDEAL is solved, outputting fat, water, R2*, and field (c). The SPURS-T 2 *-IDEAL output is then processed with background field removal using the projection-onto-dipole-field (PDF) method, and the remaining magnetic field (d) is processed to generate a susceptibility map (e) using the morphology enabled dipole inversion algorithm (MEDI). Water/fat separation was successful in all nine controls and in 17 of 18 patients. Separation failed in one patient with very high hepatic iron overload. The GRE images from this patient had a detectable liver signal only in the first echo and this patient was therefore excluded from further analyses. Figure 4 shows the water map, fat map, susceptibility map with fat contribution, and susceptibility map without fat contribution from a normal subject. The fat contribution to liver susceptibility can be corrected.
Focal lesions in patients included hemangiomas (n 5 3), hepatocellular carcinoma (HCC, n 5 1), suspected cholangiocarcinomas or metastases (n 5 3), multiple malignant tumors ). This contrast did not coincide with the smooth spatial distribution of iron overload, but was spatially concordant with the sharp contrasts in the T 1 -weighted and T 2 -weighted images. The mean susceptibility without fat contribution was 0.081 ppm in the lesion, which gradually increased to 0.455 ppm in the neighboring normal-appearing liver tissue. Figure 6 shows the results from a patient with multiple liver metastases after interventional therapy with transarterial chemoembolization using Lipiodol. The metastases displayed a complex inhomogeneous signal on R2* (Fig. 6c) , but there were only marginal changes on QSM (Fig. 6d) . Residual bright spots were present on QSM (Fig. 6d) at the treated site, consistent with hemorrhage. Figure 7 shows the R2* and susceptibility maps from a normal subject and a patient with moderate iron overload. As iron levels increased, both susceptibility and R2* increased. For the patient with moderate iron overload, there was also suspected fibrosis in the left lobe that did not affect QSM but increased R2* (red arrows in the 2 nd row).
For all subjects with no known hepatic disease and those with known or suspected hepatic iron overload, there was no linear correlation between liver magnetic susceptibility and R2* in ROIs without lesions when R2* < 100 sec 21 (P 5 0.35, Fig. 8b ). However, a moderate linear correlation was seen over a large R2* range up to near 500 sec 21 (R 2 5 0.797, P < 0.0001, Fig. 8a ).
Discussion
Our phantom data clearly demonstrate the strong nonlinear interfering effects of fibrosis and fat in the R2* estimation of [Gd] ; this finding is consistent with the known complex nonlinear relationship between deoxyheme iron and R2* in calibrated fMRI. 13 The cellularity effects on R2 form the foundation for diagnosing lesions on T 2 -weighted imaging in clinical MRI, but they interfere with R2 and R2*(5R21R2 0 ) iron estimation. The interfering effects of cellular pathology may help explain the very large error range in the current FDA-approved R2-based LIC measurement. 5, 8 This large error cannot be explained by biopsy sampling variability, which is about 67% for biopsies with a dry weight of 1 mg or more in cirrhosis-free livers. 10 Our in vivo data on liver iron mapping in 27 subjects demonstrate that liver pathology, including cysts, fibrosis, hemangioma, hepatocellular carcinoma, cholangiocarcinoma, and fatty infiltration, generates R2* image contrasts, interferes with R2* estimation, but has little or no effect on QSM. Lesions without fat or hemorrhage may have strong contrasts on R2*, typically hypointensity or decreased values, but no contrast on QSM, consistent with the smooth spatial distribution of iron overload. 2, 10 The fat contribution to susceptibility was corrected on QSM according to a linear tissue composition model. Our results suggest that QSM without lesion contrasts can be virtually immune to R2* cellularity interferences, making QSM accurate for quantifying LIC. These examples are intended to illustrate the effects of a variety of liver lesions on R2* and their virtual elimination with QSM. The regional contrast difference between R2* and QSM is also noticeable in a recent publication. 25 The lack of linear correlation between R2* and QSM for moderate liver iron overload (Fig. 8b) , a finding similar to recent work on QSM versus R2* for LIC estimation, 25 suggests the presence of substantial interference by fibrosis on R2*.
Clinically, a challenge in the current MRI measurement of LIC is to correct for R2 and R2* cellular interference, 3, 6 including fibrosis, fat, inflammation, and other cellular changes that are often associated with tissue damage from iron overload. 33 Fibrosis interference on R2 and R2* is strong and depends on the detailed microenvironment of the water-fibrosis interaction, 13 in a complex manner that is influenced not only by the fibrotic stage, but also by the distribution of fibrosis within a voxel. 5 The contribution of captured free water by fibrosis may significantly increase the correlation time of water FIGURE 8: There was (a) a moderate linear correlation between liver magnetic susceptibility and R2* in ROIs over all the data points with R2* <500 sec 21 ; (b) but no linear correlation over data points with R2* <100 sec 21 .
FIGURE 7: R2* (left column) and susceptibility (right column) maps from a normal subject (top row) and a patient with moderate iron overload (bottom row). For the patient with moderate iron overload, there was suspected fibrosis in the left lobe (red arrows), which increased R2* but did not affect QSM.
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protons, and hence, the R2 relaxation rate. In contrast, weakly diamagnetic fibrosis contributes linearly to susceptibility, and no appreciable contrast may be present on QSM for moderate fibrosis. Fundamentally, R2 and R2* are derived from the MRI signal magnitude, which depends on cellularity in complex ways that are difficult to quantify. 13 Monte Carlo modeling can be used to investigate clinical iron calibration curves in vivo, 34 but requires detailed prior knowledge including concentration, susceptibility, particle size, distribution, and volume fraction for each tissue component in the liver. Similarly, the fat fraction can be well quantified in the presence of iron primarily using the unique chemical shifts of fat 6, 12, 35 ; its linear contribution to QSM can be corrected for iron quantification. In contrast, the fat interfering effects on R2 and R2* depend on the detailed microenvironment of the water-fat interaction and the fat spatial distribution within a voxel, both of which are difficult to model and counteract. It should be noted that, in theory, fat suppression does not affect the fat contribution to the relaxation of the cellular microenvironment (R2), the electronic susceptibility, or R2* of water, 13 assuming no exchange between fat and water protons. In practice, spectral imperfections in fat suppression pulses interfere with R2 and R2* estimation. 36 Fortunately, MRI signal phase allows rigorous biophysical modeling for the determination of tissue magnetic susceptibility in QSM. 13, 29 As a molecular electron cloud property, standard linear chemical decomposition can be applied to tissue susceptibility, thus enabling iron quantification with a direct biophysical definition. Similarly, QSM may correct for susceptibility contributions from other cellular sources to accurately measure iron. This correction task has been made simple by the fact that fibrosis and most other types of cellular interference have very small susceptibilities relative to water. The prevalent moderate hepatic fibrosis in patients with transfusional iron overload may cause negligible susceptibility but substantial R2* effects. 4, 7, 8 Consistent with the literature, 6, 35 we observed decreased R2* in the presence of liver metastases, hemangioma, and malignant tumors, whereas the susceptibility values in these lesions were similar to adjacent normal liver. This can be explained by increases in water content in lesions that reduce R2* but have negligible effects on susceptibility. Liver fat increased R2*. The residual Lipiodol in metastases was seen as increased fat and strongly increased R2*, but had little effect on QSM. The residual bright spots on QSM at treated sites may be explained by hemorrhage that occurred during interventional treatment. The case of suspected HCC may present particularly interesting findings. The liver tissue neighboring the lesion has a mean R2* of 121 sec 21 and susceptibility of 0.455 ppm, high values indicative of iron overload. The QSM reveals a gradual decrease from the lesion periphery to the lesion center, which may be related to hypervascularity and inflammation at the tumor margins with necrosis in the tumor center.
In this work, liver tissue susceptibility was modeled from paramagnetic iron (with gadolinium substituted in the phantom studies) and fat. Through signal phase analysis, the chemical shift of fat allows fat quantification (SPURS 1 T 2 *-IDEAL 24 ) and subsequent QSM. [22] [23] [24] The intravoxel mixture of fat and water with different susceptibilities causes additional field inhomogeneity within a voxel and increases the apparent R2* that depends on imaging parameters including voxel size, field strength, and echo time. 12 Marked iron overload may dominate contributions to R2* and lead to a linear correlation between QSM and R2*. 23, 25 The linear correlation between liver magnetic susceptibility measured on QSM and R2* is lost in patients with mild iron overload and hepatic fibrosis, which are prevalent complications among patients with transfusional iron overload. 4, 7, 8 This lack of correlation between R2* and QSM is likely due to the interfering effects of fibrosis that affect R2* but not susceptibility. Breath-hold scans were performed for liver QSM data acquisition to reduce respiratory motion artifacts. The long TR and TEs in a standard 5-minute brain QSM protocol are not acquired for liver QSM, so that the scan time is drastically shortened to fit within a breath-hold. As known from T 2 w, the optimal sampling TE to maximize T 2 * contrast in T 2 *w is T 2 *. For field unwrapping and minimal distortion, QSM data should be acquired using high bandwidth with multiple echoes. Therefore, TEs larger than T 2 * are not acquired, as they are not T 2 * CNR-efficient. However, TEs smaller than T 2 * are acquired to fully utilize all available time for data sampling. Hence, we set the maximal sampling TE to be around a targeted T 2 * of $15 msec.
Patients with no known hepatic disease and those with known or suspected hepatic iron overload were scanned on 1.5T and 3T systems. QSM reproducibility has been reported between 1.5T and 3T scanners for both brain 18, 19 and liver. 23 Magnetic susceptibility measured on QSM as an intrinsic tissue magnetic property determined by electron clouds is independent of field strength. Therefore, it is meaningful and practical to compare QSM across all subjects at various field strengths. However, our comparison of QSM with R2* (1/T 2 *) is limited to one field strength (1.5T), because T 2 * is an MRI signal voxel decay model parameter that is not an intrinsic tissue property and is highly dependent on field strength and other imaging parameters.
There are some limitations to this study. The number of patients was relatively small. Patients with focal lesions were useful in validating QSM's effectiveness for overcoming R2* cellular interference in mapping LIC. Patients with liver fibrosis caused by diffuse iron overload are of great clinical concern and will be a focus of recruitment in future studies. Water/fat separation failed in a patient with severe hepatic iron overload and the subsequent extremely rapid signal decay. To generate QSM and R2*, ultrashort echo time sequences may be used to acquire sufficient signal on patients with very rapid T 2 * signal decay. 37 We did not correlate our findings with biopsy iron quantification and immunohistochemistry assays. Biopsies were not performed on these patients, but would provide iron validation on LIC estimates by QSM and R2*. Biopsy immunohistochemistry would also help us interpret QSM and R2* in a molecular/ cellular mechanistic manner similar to studies on white matter lesions in multiple sclerosis. 38 The fat contribution to liver susceptibility was compensated for by using the signal intensities of liver and subcutaneous fat in the fat image after correcting for intensity inhomogeneity due to receiver coils. The proton density fat fraction (PDFF) map can be generated from the multigradient-echo images; this has been shown to be an accurate, repeatable, and reproducible measure of liver fat concentration. 3, 6 In future work, Eq. 1 can be modified using PDFF. Both 1.5T and 3T scanners were used in this study due to their availabilities for phantom and patient studies. This may be justifiable for studying moderate liver iron overload in the majority of thalassemia major patients cared for in the USA according to the established reproducibility of R2* 36, 39, 40 and QSM 18, 19 at these two field strengths. As R2 data were not available in patient studies, this study was limited to comparison of QSM with R2*. Ferritin iron stores were not available for constructing phantoms. The relaxation effects in liver iron overload with fibrosis are highly dependent on the microenvironment of the fibrosis-iron-water interactions and may involve interconnected components of fibrosis, increasing correlation time, inner sphere effects of proton exchange with iron complexes, and outer sphere effects of water protons diffusing in the vicinity of paramagnetic iron. 13 Our collagen-gadolinium-water phantoms may have similar levels of fibrosis, increased correlation time, and demonstrate the outer sphere effects of water proton diffusion in the vicinity of paramagnetic gadolinium. However, they may have differing inner sphere effects of proton exchange with gadolinium molecules. In studying liver fibrosis, its dominant effect of increasing correlation time would largely be replicated in the collagen-gadolinium-water phantom.
In conclusion, fibrosis, fat, edema, and other cellular pathology may interfere with R2* estimation of LIC. QSM virtually eliminates such cellular interference for mapping LIC.
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